Hemogenyx Pharmaceuticals Share Discussion Threads

[tsmith2] 20/2/2020 08:10

Buy and tuck away for a multibagger stock

[badger60] 20/2/2020 08:09

Those luck enough to have got shares at the recent new issue should be very happy imv!

[badger60] 20/2/2020 07:40

Fantastic news.....another important product building block.

[marie1980] 20/2/2020 07:25

Great RNS!

[tsmith2] 20/2/2020 07:20

Excellent news

[on target] 20/2/2020 07:17

Nice news, and good call purple.

[on target] 19/2/2020 11:40

They have been silent on the offer of grant/loan funding from the Belgian goverment since the November update. Could be related to potential moves from Orgenesis, or they just didn't bother to update us yet. Either way we are well overdue an update on Hu-Phec progress.

[elpirata] 19/2/2020 09:46

On Target

The previous investment in Hemogenyx-Cell was at a valuation of $12m

dont forget to factor in

Orgenesis will exclusively supply Hemogenyx Product under a separate Manufacturing and Supply Agreement at the end of the clinical development stage


Under the terms of the collaboration agreement, Hemogenyx-Cell has granted Orgenesis and its Affiliates a perpetual, non-exclusive, worldwide, sublicensable through multiple tiers license to use, manufacture, make, market, sell and otherwise commercialize the Hemogenyx technology, Hemogenyx patents and/or Hemogenyx Products (“License̶1;). In consideration for the License, Orgenesis shall pay Hemogenyx-Cell a royalty of 12% of Orgenesis’ net revenues generated from Hemogenyx’ technology

and of course the newly granted Hu Phec patent which now validates and underpins the Hemo IP

[scaramouche1941] 19/2/2020 03:10

The most important outcome from all Hemo’s activities would be an investment by the global pharmaceutical company, whatever form that investment might come in. This would surely validate the whole story behind Hemo’s development.

[scaramouche1941] 19/2/2020 03:07

Hemo concentrates on AML and most likely has no resources to move anything else forward. It is better to have at least one advanced product candidate.

[on target] 17/2/2020 12:15

Orgenesis (NASDAQ:ORGS) the company that previously invested $1m into Hemogenyx-Cell, the subsidiary of HEMO working on Hu-PHEC, have just received $130m cash from the sale of one of their subsidiaries.

In a news release on Friday ORGS said

"Orgenesis expects to use the net proceeds from the Sale to continue to grow its point-of-care cell therapy business and to further the development of Advanced Therapy Medicinal Products."

There must be a good chance ORGS will seek to 'top-up' a few of its investments in the cell therapy area, or maybe even buy a few outright?

The previous investment in Hemogenyx-Cell was at a valuation of $12m, so perhaps $15m-20m and a small royalty would be acceptable to buy the whole subsidiary? I note there was no mention at all of Hu-PHEC in the recent funding announcement, nor any mention of its current status or HEMO's plans for it in the patent news last week when there was the perfect opportunity to do so.

Any thoughts?

[on target] 13/2/2020 09:05

Nice and quiet today..

[davevt] 13/2/2020 08:27

So how's that post placing share price holding up..?

[purple11] 12/2/2020 10:20

being 9.8%down on the day does matter however you spin it.

[elpirata] 12/2/2020 09:37

do short terms share price trends matter purple? not if you're in for the end game, but yes if you're looking to trade/top slice

[purple11] 12/2/2020 09:33

so frustrating.can never seem to hold any gain.

zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz…;……...………………………;….

[seanlander] 11/2/2020 07:24

Good news then... nice time to get a top up yesterday. Thanks for the advice guys!!

[marie1980] 11/2/2020 07:05

WOWOWOWOW!!!


A patent application “Post-Natal Hemogenic Endothelial Cells and their isolation and use” has been approved by the US Patent and Trademark Office. The patent will be issued on 25 February 2020 as Patent Number 10,570,373.

[marie1980] 10/2/2020 19:20

Agree next link.. better to ignore.

[nextlink] 10/2/2020 13:57

Purple11 I get the feeling we have a double act, possibly the
one individual with two profiles.
Difficult i know, but not engaging is the best policy.

[davevt] 09/2/2020 01:09

Sorry John, I wrote it wrong, I meant she owns more shares that are worth more than yours 😅